SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-024383
Filing Date
2024-10-02
Accepted
2024-10-02 16:15:16
Documents
1
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 form4-10022024_041008.html 4  
1 form4-10022024_041008.xml 4 3394
  Complete submission text file 0001415889-24-024383.txt   5138
Mailing Address 685 ROUTE 202/206 N., SUITE 301 BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206 N., SUITE 301 BRIDGEWATER NJ 08807 800-775-7936
VYNE Therapeutics Inc. (Issuer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O VYNE THERAPEUTICS 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807
Business Address
Zeronda Tyler (Reporting) CIK: 0001867033 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38356 | Film No.: 241347518